Skip to main content

Gastroparesis clinical trials at UCSD
3 in progress, 1 open to new patients

  • A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis

    open to eligible people ages 18 years and up

    This study will evaluate the safety and efficacy of Relamorelin compared to placebo in patients with diabetic gastroparesis. Patients will report daily severity scores of their diabetic gastroparesis symptoms.

    La Jolla, California and other locations

  • A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

    Sorry, accepting new patients by invitation only

    A 46-week study to compare the efficacy of relamorelin with that of placebo in participants with diabetic gastroparesis (DG). At the end of the 40-week Treatment Period, participants will either continue on relamorelin or placebo for 6 additional weeks.

    La Jolla, California and other locations

  • A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

    Sorry, not currently recruiting here

    A 52-week study to compare the efficacy of relamorelin with that of placebo in participants with diabetic gastroparesis (DG) with respect to the core signs and symptoms of diabetic gastroparesis.

    La Jolla, California and other locations